東京大学医科学研究所

  1. ホーム
  2. イベント情報■学友会セミナー

学友会セミナー

学友会セミナー:2018年12月5日

開催日時: 2018年12月5日 18:00 ~ 19:00
開催場所: 1号館2階 2-3会議室
講師: 1.杉浦 亙

2.Charles Hicks
所属: 1.Asia-Pacific Regional Medical Director, ViiV Healthcare Company

2.Global Medical Director, ViiV Healthcare company, Professor of Medicine, Voluntary Faculty, University of California, San Diego
演題: 1.The role of integrase inhibitor and the resistance barrier for HIV infection, treatment and upcoming future

2.The impact of 2 drug regimen, Co-morbidities and Co-infection of HIV/HBV or HIV/HCV in the era of 2 drug regimen
概要:

1.The first topic of the day will be “Resistance in the era of 2-drug HIV integrase inhibitors-based ART” presented by Dr Wataru Sugiura. This presentation will review data on the barrier to resistance among HIV integrase inhibitors including data from 2-drug ART regimen trials. Ensuring the long-term efficacy of currently used drugs such as doltegravir is key, but the role of future antiretroviral agents may also be crucial to HIV treatment strategies in the future.

2.the second presentation, Dr. Charles Hicks will focus on the recent data regarding ART management of PLWH who have multiple co-morbidities, an increasingly important issue given that long-term survival has resulted in significant increases in the proportion of PLWH who are age 50 or greater. This presentation will discussion of the role of 2-drug HIV integrase inhibitor-based therapy in treating patients with multiple co-morbidities.

世話人: 〇四柳 宏 (感染症分野)
 俣野 哲朗 (エイズワクチン開発担当)